Marian Wentworth

In a recent conversation with global development media platform Devex, MSH’s President and CEO Marian Wentworth talked about her new role, her transition from the private sector, and her overall views on the challenges and opportunities facing global health. The following are excerpts from the article originally published on Devex on March 27, 2017, by Amy Lieberman. What do you hope to bring to MSH, and what changes would you like to see in the organization?

{Photo credit: Jean Jacques Augustin}Photo credit: Jean Jacques Augustin

The Ending Preventable Maternal Mortality working group has written a letter to the editor of The Lancet, which was published in the February 18 edition of the journal. Amy Boldosser-Boesch, Senior Director of the FCI Program of MSH, represents MSH in the working group and co-wrote the letter.

{Photo Credit: Michael Paydos/MSH}Photo Credit: Michael Paydos/MSH

Tuberculosis is one of the top causes of death globally. In many of the countries most affected by this disease, drug sellers—also known as private pharmacies—are the first point of contact for people seeking health care. By some estimates, about 50 percent of TB patients’ first contact with the health system is from a private pharmacy.


Printer Friendly Version